STENTYS appoints Christophe Lottin as new CEO

– FRANCE, Paris / USA, NJ – STENTYS (Euronext Paris:STNT), a medical technology company commercializing the world’s first and only Self-Apposing® coronary stent, today announces that the Board of Directors has appointed Christophe Lottin as the new Chief Executive Officer of the Company.…